Results 231 to 240 of about 73,005 (301)

Indirect effect and pneumococcal conjugate vaccines

open access: yesПедиатрическая фармакология, 2009
L. Temimi
doaj   +2 more sources

Incidence of all-cause and vaccine-preventable, radiologically confirmed community-acquired pneumonia in hospitalised adults in Germany: a multicentre surveillance study (2021-2023). [PDF]

open access: yesBMJ Open
Theilacker C   +11 more
europepmc   +1 more source

Recent progress on stimuli‐responsive chitosan‐based biomaterials as drug carriers

open access: yesInterdisciplinary Medicine, EarlyView.
This review discusses the recent progress in chitosan‐based drug delivery systems that respond to pH, redox, enzymes, reactive oxygen species, and combined stimuli. It examines design strategies, key mechanisms, and therapeutic applications, and also addresses current challenges while suggesting future approaches to enhance clinical translation and ...
Changlu Xu   +4 more
wiley   +1 more source

Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]

open access: yesHum Vaccin Immunother
Giriappa B   +11 more
europepmc   +1 more source

Rapid Interventions to Limit Outbreak of Invasive Streptococcus pneumoniae in Correctional Facility, North Carolina, USA, 2024. [PDF]

open access: yesEmerg Infect Dis
Gowler CD   +10 more
europepmc   +1 more source

Biological treatments for zoonotic salmonellosis: an evolving therapeutic landscape. [PDF]

open access: yesFront Microbiol
Ma S   +7 more
europepmc   +1 more source

Country-level perspectives and priorities to guide the development of Invasive non-Typhoidal Salmonella (iNTS) vaccines: Insights from seven countries. [PDF]

open access: yesPLoS Negl Trop Dis
Spasenoska D   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy